VistaGen Therapeutics, Inc. 4
4 · VistaGen Therapeutics, Inc. · Filed Apr 28, 2017
Insider Transaction Report
Form 4
Smith Mark Alan
CHIEF MEDICAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2017-04-26+125,000→ 125,000 totalExercise: $1.96Exp: 2027-04-26→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]One third (1/3rd) of the total shares shall vest one (1) year following the date of grant and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested three (3) years from the date of grant.